SCHEMBL8290202

SCHEMBL8290202

CCC(CN)CC(C)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18576430 1.00
SCHEMBL12081863 0.87
SCHEMBL8470160 0.84
SCHEMBL14983858 0.81 TDP1 (0.39)
SCHEMBL8160608 0.80
SCHEMBL5322429 0.80
SCHEMBL28993340 0.80
SCHEMBL28299569 0.79 ALDH1A1 (0.46)
Hydrochloric Acid SCHEMBL28671037 0.78 CACNA2D1 (0.59)
SCHEMBL10054693 0.76 CACNA2D1 (0.69)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240016946-A1 DRUG-LOADED MACROMOLECULE AND PREPARATION METHOD THEREFOR SHANGHAI SHENGDI PHARMACEUTICAL CO., LTD. (CN) 2024-01-18 US disclosed
US-8420067-B2 Targeted polylysine dendrimer therapeutic agent STARPHARMA PTY LTD (AU) 2013-04-16 US disclosed
US-8258259-B2 Macromolecular compounds having controlled stoichiometry STARPHARMA PTY LIMITED (AU) 2012-09-04 US disclosed
US-20100292148-A1 TARGETED POLYLYSINE DENDRIMER THERAPEUTIC AGENT STARPHARMA PTY LTD. (AU) 2010-11-18 US disclosed
US-20100278750-A1 POLYLYSINE DENDRIMER CONTRAST AGENT STARPHARMA PTY LTD 2010-11-04 US disclosed
WO-2005032468-A2 MONOCYCLIC AND BICYCLIC LACTAMS AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2005-04-14 WO disclosed